In a retrospective study we examined a consecutive group of diabetic patients (74 operated eyes) who underwent phacoemulsification and intraocular lens implantation over a 2 year period ending in June 1994. We compared this group with 66 diabetic eyes who underwent extracapsular surgery and lens implan tation and who were examined for a previous study.
In a retrospective study we examined a consecutive group of diabetic patients (74 operated eyes) who underwent phacoemulsification and intraocular lens implantation over a 2 year period ending in June 1994. We compared this group with 66 diabetic eyes who underwent extracapsular surgery and lens implan tation and who were examined for a previous study.
There were no significant differences in progression of the retinopathy, complications, or final visual acuity. 
PATIENTS AND METHODS
The theatre records of all patients who underwent phacoemulsification under the care of one consultant surgeon over an 18 month period between January 1993 and June 1994 were examined. The medical coding records of these patients were then examined and the records of those patients who were diabetic were extracted for detailed examination. The patients were then recalled and examined by one of the authors. Seventy-five patients were included. Ten patients had died over the follow-up period; two of these patients who had been seen in the clinic with adequate follow-up (minimum of 6 months) were included. Four patients were lost to follow-up.
Eleven patients had both eyes operated on. Sixty one patients (72 eyes) were re-examined by one of the authors. A total of 63 patients (74 eyes) were therefore included.
All patients underwent phacoemulsification with implantation of a posterior chamber lens. Fifty eyes had a 5 mm optic, 7 had a 6 mm optic and 17 had a 6.5 mm optic implanted. Fifty-seven operations were carried out by one consultant surgeon and 17 by six different trainees.
Thirty of the eyes were from men and 44 from women. The ages ranged from 31 to 88 years (mean 67 years). The mean duration of follow-up was 12 months. Two patients were controlled by diet, 36 by oral hypoglycaemic agents, 35 were on insulin (11 of whom had originally commenced on oral hypoglycaemic agents), and 1 patient was on both oral hypoglycaemic agents and insulin. The duration of disease in the oral hypoglycaemic group ranged from 1 to 43 years (mean 10.1 years) and in the insulin-dependent group ranged from 7 to 40 years (mean 23.3 years).
These patients were then compared with a similar group of diabetics who underwent extracapsular cataract extraction and who were examined for a previous study.
6 The extracapsular eyes were from men in 28 cases and women in 38 cases (chi-squared = 1.28, p>O.I ). Six patients had both eyes operated on. The mean age was 70.5 years and the mean duration of follow-up was longer, at 2.61 years. Eleven patients were controlled by diet, 39 by oral hypoglycaemics, 15 were on insulin and 1 required both insulin and oral hypoglycaemics (Fig. 1) .
RESULTS Visual
There was no statistically significant difference in visual outcome between the two groups. In the phacoemulsification group 74% achieved a visual acuity of 6/12 or better compared with 68% of the extracapsular group (chi-squared = 0.38, p>0.5; Fig.  2 ). Seventy-two per cent of the phacoemulsification group improved by 2 or more lines of Snellen visual acuity compared with 76% of the extracapsular group (chi-squared = 0.13, p>0.5). There was no difference in visual outcome between those on insulin and those on oral hypoglycaemic agents.
As with the previous study, the visual results were poorest in those with maculopathy or proliferative retinopathy ( Table I) . Sixteen eyes out of 31 with maculopathy improved by 2 or more lines (Fig. 3) and 16 eyes out of 27 with proliferative retinopathy improved by 2 lines. Nineteen eyes failed to achieve 6/12 at the follow up visit. One patient had age-related macular degeneration and the other 18 all had maculopathy at final follow-up (Table II) 
Progression of Retinopathy
Twenty-five eyes showed progression of retinopathy post-operatively (Table III) . Twenty-three eyes required photocoagulation post-operatively. Two eyes had panretinal photocoagulation (PRP), 12
eyes had macular treatment and 9 eyes had both PRP and macular laser treatment.
Complications
There were few peroperative complications. There were 3 capsule ruptures, 2 requiring anterior vitrectomies. On 2 occasions the capsulorhexis was converted to a caps ulotomy and twice the capsulo rhexis was torn. There were 2 zonular dehiscences and 1 iris tear. This compares with no peroperative complications in the extracapsular group.
The most common post-operative complication was capsular thickening. This occurred in 20 (27 %) of the phacoemulsification group (Table IV) In the phacoemulsification group 16 eyes had the optic only partially inside the bag (both hap tics were in the bag), but none of these optics was displaced (Fig. 4) . Overall there were fewer postoperative complications in the phacoemulsification group, but 8 eyes had transient corneal oedema and 8 eyes had transiently raised intraocular pressure (>25 mmHg), whereas none of the extracapsular eyes suffered from this complication.
DISCUSSION
The phacoemulsification group had a greater propor tion of insulin-dependent diabetics to non-insulin dependent diabetics than the extracapsular group previously reported 6 ( Fig. 1) . There was also a greater proportion of diabetics with proliferative retinopathy preoperatively (chi-squared = 8.12; 0.02>p>0.01), and a greater proportion of diabetics with maculopathy (chi-squared = 2.1; p>O.l). R. J. ANTCLIFF ET AL. 
